Starsita-100
Description_Effects
Starsita-100 contains Sitagliptin 100 mg, a DPP-4 (dipeptidyl peptidase-4) inhibitor used for the effective management of Type 2 Diabetes Mellitus. It is an oral antidiabetic medication designed to help control blood sugar levels, especially in adults who are unable to manage their condition with diet and exercise alone. Sitagliptin works by enhancing the body’s natural incretin system. Incretins are hormones released during meals that help regulate blood sugar. Sitagliptin increases insulin secretion in response to meals and reduces the secretion of glucagon (a hormone that raises blood sugar levels) when blood glucose is high. This dual action helps lower both fasting and postprandial (after-meal) blood glucose levels. Starsita-100 is typically used as monotherapy or in combination with other antidiabetic agents such as Metformin, Sulfonylureas, or Thiazolidinediones, depending on individual patient needs. When used consistently along with a healthy diet and regular physical activity, Starsita-100 not only helps in maintaining target blood glucose levels but also reduces the risk of long-term diabetes complications, such as kidney damage, nerve disorders, and cardiovascular issues. It is generally well-tolerated, with a low risk of hypoglycemia and no significant impact on body weight. Regular monitoring of blood glucose and follow-up with a healthcare provider is essential for optimal results.
